ABSTRACT Introduction: Total body iron store is an integral factor in the development of hair follicle. Numerous studies have been done seeking for the relationship between body iron store and various forms of chronic diffuse hair loss, with relatively contradictory findings in various reports in these studies. The main objective of this study is to find out if there is any association between total body iron store and various types of chronic diffuse hair loss in females in reproductive age. Materials and Methods: This is a hospital based case control study conducted in Nobel Medical College and Teaching Hospital, Biratnagar, Nepal. Sixty female patients of age group 15-50 years with chronic diffuse hair loss with equal number of age-and sexmatched controls were studied. Both of the study groups were evaluated for various parameters of iron status. Results: The mean value of serum ferritin in cases was significantly lower as compared to controls (p=0.018). Patients with alopecia areata (p=0.008) and androgenetic alopecia (p=0.021) had significantly lower serum ferritin, whereas there was no statistically significant difference in telogen effluvium and controls (p=0.857).The mean value of hemoglobin, hematocrit and mean corpuscular hemoglobin was found to be significantly lower in alopecia areata and androgenetic alopecia. However, there was no statistically significant difference in RBC indices of patients of telogen effluvium and controls. Conclusion: Diffuse chronic hair loss shows definite association with serum ferritin and various RBC indices in female of reproductive age group. Alopecia areata and androgenetic alopecia show major association with total body iron stores.
INTRODUCTION
Hair, having no any specific physiological importance in human, has significant social, psychological and cosmetic importance. Chronic diffuse hair loss, in women is associated with great distress.
A human scalp on average has about 100,000 hairs. Each hair grows for about 1000 days and 100 telogen hair shed. 1 Hair passes through three stages of growth and shedding. The hair follicles are not synchronized in growth. The stages include anagen (86%), catagen (1%) and telogen (13%). 2 Alopecia by definition is the loss of hair from a normally hairy area. 3 Diffuse hair loss usually occurs without inflammation or scarring. The loss affects hairs throughout the scalp in a more or less uniform pattern. 1 Like other organs hair also needs adequate nutrition as evidenced by its affect in various nutritional diseases. 4, 5 Protein energy malnutrition in particular causes significant hair changes. 4, 5 Besides this, various micronutrients have also been implicated as etiological factors of hair loss. 6, 7 Iron deficiency is the most common nutritional deficiency disorder of the world. Hb, Hct, MCV, MCHC, MCH and serum ferritin correlate with the amount of total body iron store. Ever since one of the earliest study performed by Hard in 1963, comparing the relationship between diffuse scalp hair loss and iron deficiency as measured by serum iron, various contradictory studies have been published. 6 A case control study by Rushton et al. showed that almost three-quarters of 50 premenopausal women with diffuse scalp alopecia had serum ferritin level less than 40 mcg/L. 7 Therefore this study was done to evaluated the relationship between chronic diffuse hair loss and total body iron status.
MATERIALS AND METHODS
The Institutional Review Committee approved the study. The study was conducted from 1st march 2017 to 28 February 2018. Written consent was taken from all the study subjects before their inclusion in the study. The study comprised of 120 female patient of reproductive age group (15-50 years) presenting to the dermatology department of Nobel Medical College and Teaching Hospital, Biratnagar, of which 60 were case and 60 controls. The diagnosis of various types of alopecia was made on the basis of history and clinical examination. Androgenetic alopecia, telogen effluvium and alopecia areata were included in the study. Inclusion criteria for cases: all the consenting female patients of age group 15-50 years with chronic hair loss. Exclusion criteria for cases: Participants on iron, folic acid, vitamin B12, pregnancy in the preceding one year, undergoing major surgery, endocrine abnormalities, on medication for systemic disorders and acute inflammatory condition. Inclusion criteria for controls: the control group comprised of age and sex matched patients presenting to the dermatology department for some other dermatological abnormality not directly related to alopecia of iron deficiency.
Exclusion criteria for controls: Participants on iron, folic acid, vitamin B12, pregnancy in the preceding one year, undergoing major surgery, endocrine abnormalities, on medication for systemic disorders and acute inflammatory condition. The baseline investigations used to measure the total body iron store included serum ferritin, blood hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular hemoglobin (MCH).
The parameters for the study of total body iron status was performed on venous blood using Chemico Lumino Immuno Assay (CLIA) for serum ferritin and Fully Automated Cell Counter for (Hb, Hct, MCV, MCHC and MCH). The normal values for serum ferritin was taken as 20-200ng/mL and Hb, Hct, MCV, MCHC, MCH were12-16gm/dl, 36-48%, 80-96fL, 33-36gm/dL, 30-33pg respectively. The analysis of the data was performed by using SPSS version 22. The statistical analysis of the data was done using mean ± standard deviation, and independent t-test. The test was referenced for p values and p value of less than 0.05 was taken to be significant.
RESULTS
The age range of cases and controls in our study was 15-50 years with mean age of 33.93 ± 11.02 years in cases and 34.97± 10.42 years in controls. Out of 60 female patients of alopecia, 23 were suffering from alopecia areata, 18 from androgenetic alopecia and 19 had telogen effluvium.
The mean value of hemoglobin (9.38 ± 1.66 g/dl c.f. 10.48 ± 1.61 g/dl; p=0.001), hematocrit (29.47 ± 5.48% c.f.32.06 ± 6.16%; p=0.016) and mean corpuscular hemoglobin (27.07 ± 3.54 pg c.f.29.13 ± 3.87 pg; p=0.003) was found to be significantly lower than the control group in our study. But Mean corpuscular volume (81.23 ± 8.47 fl) and Mean corpuscular hemoglobin concentration (30.85 ± 1.82 g/dl) were not significantly lower than that of controls as shown in Table 1 .
The mean serum ferritin in cases (19.68 ± 8.70 ng/ ml) was found to be significantly lower than controls (23.14 ± 6.99 ng/ml) [p=0.018] as shown in Table 2 . On further analysis of subgroups of alopecia, the mean serum ferritin in alopecia areata (18.12 ± 8.70 ng/ml) and androgenetic alopecia (18.39 ± 9.14 ng/ml) was significantly lower than that in controls (p=0.008 and p=0.021 respectively). Although the mean serum ferritin of patients with telogen effluvium (22.79 ± 7.85 ng/dl) was lower than that of controls (23.14 ± 6.99 ng/ml), but there was not statistically significant difference (p=0.857) as shown in Table 2 .
We further analyzed the data of various RBC indices on different subgroups of alopecia. The mean value of hemoglobin, hematocrit and mean corpuscular hemoglobin was found to be significantly lower in alopecia areata and androgenetic alopecia, whereas mean corpuscular volume and mean corpuscular hemoglobin concentration was not significantly different from that of controls as shown in Table 3 .
However, there was no statistically significant difference in RBC indices (Hb, Hct, MCV, MCH, MCHC) of patients of telogen effluvium and that of controls as shown in Table 4 .
DISCUSSION
Our result shows that alopecia areata was most common type of non scaring alopecia, followed by telogen effluvium and then androgenetic alopecia.
Diverse result has been observed regarding the relation between non scaring alopecia and serum ferritin level and RBC indices. So, the present case control study was done to see if there is any correlation between serum ferritin level and non scaring alopecia.
In our study we found mean serum ferritin level was significantly lower in cases than in control.
Regarding serum ferritin level our study is in correlation with Kantor et al. and Chitsi et al. who also found mean serum ferritin level to be significantly lower in cases than in control. 8,9 our study contrast with study done by Oslen et. al. and Sinclair who shows there is no association between alopecia and serum ferritin. 10, 11 On further analysis we found that serum ferritin level was significantly lower in patient with alopecia areata and chronic androgenic alopecia (p < 0.05) but in patient with telogen effluvium it was lower but not significantly lower (p>0.05).
Kantor et al. and Chitsi et al. also found serum ferritin level was significantly lower in patient with alopecia areata and androgenetic alopecia but it was lower but not significantly lower in patients with telogen effluvium like our result. 8, 9 White et al. in Denmark concluded that female patients with alopecia areata had an increased incidence of iron deficiency compared with the general population. 12 They suggested serum ferritin measurement should be a necessary part of the work up in patients with alopecia areata. Esfandiarpour I also found that serum ferritin in patient with alopecia areata to be lower but it was not significantly lower. 13 Ferritin has been reported to exhibit different immunological activities such as suppression of antibody production by lymphocytes and suppression of delayed type hypersensitivity. The ferritin levels are increased in inflammation, infections, malignancies and autoimmune diseases.
14 Since alopecia areata is an autoimmune disease, there must be changes in serum ferritin and iron levels. 15 Park SY et al. found it to significantly lower in patients with androgenetic alopecia. 16 But in contrast to our result Moeinvazir M et al. found serum ferritin to be significantly lower in patients with telogen effluvium. 17 In large population based How much value of serum ferritin to be taken as lower limit is the matter of debate for modern trichologist. Rushton and Ramsay found that women with androgenetic alopecia responded best to treatment with antiandrogen cyproterone acetate and thinly estradiol when their serum ferritin level was above 40 ng/ml. 19 Apart from serum ferritin there has also been result of other micronutrients that is associated with hair loss in women. Rasheed et al. found serum ferritin and vitamin D significantly lower in patients with androgenic alopecia and telogen effluvium. 20 Jin et al. found that no significant difference in level of serum ferritin and copper level in patients with alopecia areata but found that for serum zinc and selenium it was significantly lower. 21 In our study we also found that RBC indices like the mean value of hemoglobin, hematocrit and mean corpuscular hemoglobin were found to be significantly lower in patients than the control group in our study. But Mean corpuscular volume and Mean corpuscular hemoglobin concentration were not significantly lower than that of controls. Like our result Muzami et al. also found hemoglobin, hematocrit and mean corpuscular hemoglobin to be significantly lower in patients. 9 Serum ferritin level, Mean hemoglobin level and RBC indices were found to be in lower side in both cases and control. This may be due to high prevalence of anemia in the community of the study population of country like Nepal. One-third Nepalese women (35.0%) are suffering from anemia; 29.0% fall under mildly anemic. 22 Nepal holds the evidences of alarming rate of anemia among the women of reproductive age.
23
CONCLUSION Diffuse chronic hair loss shows definite association with serum ferritin and various RBC indices in female of reproductive age group. Alopecia areata and androgenetic alopecia show major association with total body iron stores. Apart from serum ferritin other micronutrients like vitamin D, copper, zinc and selenium may also be associated with hair loss in premenopausal female. So we suggest that iron stores, RBC indices and micronutrient profile has to be evaluated for better management of alopecia in female. We recommend the female patient presenting with hair loss has to be evaluated for RBC indices and serum ferritin level.
Limitation of study
The study would be more informative if other micronutrients like zinc, selenium, cooper and vitamin D were also evaluated as their level also correlate with hair loss in females.
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